Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
NCT04821141
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Risk Reduction
Breast Cancer
Interventions
DRUG:
Bazedoxifene and Conjugated Estrogens
Sponsor
University of Kansas Medical Center
Collaborators
[object Object]